Young adults who vaped daily but never smoked had lower flow-mediated dilation and peak oxygen uptake than peers who used neither product.
|Articles|July 27, 2021
Pharmacy Clinical Pearl of the Day: Iron Deficiency, Anemia in Heart Failure Patients
Author(s)Saro Arakelians, PharmD
Heart failure outcomes improve with optimal iron levels.
Advertisement
Clinical Pearl of the Day:
- Patients with heart failure patients must be evaluated and treated for Iron deficiency and anemia.
- Prevalence over 50% in ambulatory patients.
- Iron deficiency in heart failure is defined as: ferritin < 100 µg/L or ferritin of 100-299 µg/L with a transferrin saturation <20%.
Explanation:
Iron deficiency:
- Should be screened and treated for patients with heart failure.
- Heart failure outcomes improve as iron levels improve.
- Intravenous iron replacement is needed because oral iron replacement trials do not show benefits.
- Risk factors for iron deficiency include female sex, advanced heart failure, higher levels of NTpro BNP and C reactive protein.
Reference
Advertisement
Related to this article
In more than 262,000 UK Biobank participants, a 5-marker cardiometabolic score was linked to graded risk at each step toward CKM multimorbidity.
A disease-modifying therapy for stage 3 T1D, a second once-weekly insulin, and automated insulin delivery for T2D mark a busy year in diabetes care.
October’s pain management coverage examined postoperative suzetrigine, pharmacist follow-up for cancer-related neuropathic pain, constipation prevention, and counseling patients concerned about prescribed opioids.
CDC surveillance data show that approximately 10% of adults hospitalized with RSV died during hospitalization or within 60 days of discharge.
VAX-31 met all primary immunogenicity end points against PCV20 and PCV21 in the pivotal OPUS-1 trial.
Expert Q&A: Geisinger Investigator Discusses Low Flu Vaccination Rates, ICU Findings in Older Adults
A study author explains how pharmacists can help close vaccination gaps in rural communities and what lower ICU admission rates among vaccinated older adults may mean.
From AKI dosing to CKM therapeutic inertia, experts at ASN Kidney Week 2026 pointed to pharmacists as key to moving new kidney data into practice.
Advertisement
Advertisement
Trending on Pharmacy Times
1
Diabetes Awareness Month Opens Amid New T1D, T2D Approvals
2
October 2026 in Pain Management: 4 Updates on Treatment and Pharmacy Practice
3
What Happens Before the First Dose? 5 Steps That Shape Lung Cancer Treatment
4
Full IDWeek Data Highlights 31-Valent Pneumococcal Conjugate Vaccine Candidate in Adults
5